Ayesha Shafi

14PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.

Nicolas Gordon, Peter T Gallagher, Orly I Richter

|Sep 02, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

Beatriz German, Katherine L Morel, Teia Noel

|Aug 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

Beatriz German, Katherine L Morel, Teia Noel

|May 30, 2025
Understanding Racial Disparities in Prostate Cancer: A Multifaceted Approach.

Charles Cobbs, Gregory T Chesnut, Ayesha A Shafi

|Sep 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.

Sumaira Sardar, Christopher M McNair, Lakshmi Ravindranath

Pageof 3